A total of 84 patients with lateral epicondylitis were included in the study. The patients were randomly assigned to 3 treatment groups: mesotherapy (n = 28), prolotherapy (n = 28), and control (n = 28). Patients were evaluated before treatment and at the 3rd and 8th weeks of treatment for pain severity measured with the Visual Activity Scale (VAS) during resting, activity, and at night, and for functional status with a short version of the upper limb-specific disabilities of the arms, shoulder, and hand (Quick-Dash) and Oxford Elbow Score.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
VAS
Timeframe: All measures were conducted at baseline, after treatment, at 3th and 8th weeks follow-ups.
short version of the upper limb-specific Disabilities of Arms, Shoulder and Hand (Quick-Dash)
Timeframe: All measures were conducted at baseline, after treatment, at 3th and 8th weeks follow-ups.
Oxford Elbow Score
Timeframe: All measures were conducted at baseline, after treatment, at 3th and 8th weeks follow-ups.